Michael H. Davidson

35.3k citations
420 papers · 23.1k indexed · 8 hit papers · h-index 81

Impact in

Papers in

Michael H. Davidson

409 papers receiving 21.9k citations

Hit Papers

Fixed-dose combination of obicetrapib and ezetimibe for LDL cholesterol reduction (TANDEM): a phase 3, randomised, double-blind, placebo-controlled trial 2025 · 17 citations
1719772026199320092505007501000

Peers

Michael H. Davidson
Comparison fields: 5 of 183
  • Endocrinology, Diabetes and Metabolism 8.4k
  • Surgery 12.9k
  • Cancer Research 3.3k
  • Cardiology and Cardiovascular Medicine 4.5k
  • Nutrition and Dietetics 2.9k
Replace Harold Bays with:
Harold Bays United States
Alberico L. Catapano Italy
Terry A. Jacobson United States
Robert H. Eckel United States
Maciej Banach Poland
Chris J. Packard United Kingdom
Jennifer G. Robinson United States
Philip J. Barter Australia
Henry N. Ginsberg United States
James Shepherd United Kingdom
Michael H. Davidson relative to Harold Bays United States Harold Bays's profile →
Citations per field
00.5×1.5×
Harold Bays · 1×
Citations per year

Countries citing papers authored by Michael H. Davidson

Since Specialization
Citations

This map shows the geographic impact of Michael H. Davidson's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michael H. Davidson with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michael H. Davidson more than expected).

Fields of papers citing papers by Michael H. Davidson

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Michael H. Davidson. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michael H. Davidson. The network helps show where Michael H. Davidson may publish in the future.

Co-authors

The 25 scholars most cited alongside Michael H. Davidson, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Michael H. Davidson Line = papers co-authored together Michael H. Davidson links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown
#Work
1 20251
2 202331
3 20235
4 202353
5 202217
6 202227
7 202049
8
Abstract 13727: Effects of Ziltivekimab (ZILTI), a Novel Anti-Interleukin-6 Monoclonal Antibody, on Markers of Inflammation and Cardiovascular Risk in Patients With Chronic Kidney Disease on Hemodialysis
20193
9 201821
10
Abstract 18484: Modest Potential Association Between Reductions in Lipoprotein(a) and Major Adverse Cardiovascular Events in the Phase 3 Trials of Alirocumab versus Control
20163
11 201626
12 201410
13 20126
14 20114
15
Leczenie dużymi dawkami statyn: korzyści i bezpieczeństwo intensywnej terapii hipolipemizującej
20091
16
Updating the assessment of cardiac risk: beyond Framingham.
20099
17 2008196
18
Colesevelam HCl Decreases Atherosclerosis and May Activate Reverse Cholesterol Transport in Cholesterol-Fed Rabbits
20068
19 199718
20
A method for separating the granulosa cells, the basal lamina and the theca of the preovulatory ovarian follicle of the domestic fowl ( Gallus domesticus )
Hit paper breakdown →
1977320

About Michael H. Davidson

Michael H. Davidson is a scholar working on Endocrinology, Diabetes and Metabolism, Surgery, Cancer Research, Economics and Econometrics and Cardiology and Cardiovascular Medicine, having authored 420 papers that have together received 23.1k indexed citations. Recurring topics across this work include Lipoproteins and Cardiovascular Health (284 papers), Diabetes, Cardiovascular Risks, and Lipoproteins (140 papers), Cancer, Lipids, and Metabolism (72 papers), Health Systems, Economic Evaluations, Quality of Life (67 papers), Pharmaceutical Economics and Policy (64 papers), Lipid metabolism and disorders (33 papers), Fatty Acid Research and Health (30 papers) and Cholesterol and Lipid Metabolism (26 papers). The work is most often cited by research in Endocrinology, Diabetes and Metabolism (8.4k citations), Surgery (12.9k citations), Cancer Research (3.3k citations), Cardiology and Cardiovascular Medicine (4.5k citations) and Nutrition and Dietetics (2.9k citations). Michael H. Davidson has collaborated with scholars based in United States, Australia and United Kingdom. Frequent co-authors include James M. McKenney, Kevin C. Maki, Peter H. Jones, Harold Bays, Christie M. Ballantyne, Evan A. Stein, Terry A. Jacobson, Joseph L. Witztum, Ronald Goldberg and Peter P. Tóth. Their work appears in journals such as The American Journal of Cardiology, Journal of clinical lipidology, Journal of the American College of Cardiology, Atherosclerosis and Current Atherosclerosis Reports.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026